Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.
Cancer
; 121(3): 403-12, 2015 Feb 01.
Article
en En
| MEDLINE
| ID: mdl-25251053
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Ováricas
/
Anticuerpos Biespecíficos
/
Neoplasias Glandulares y Epiteliales
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Idioma:
En
Año:
2015
Tipo del documento:
Article